May 6, 2024 Beyond the Scrubs: C-Path Nurses Smith, Heavner Share Their Insights for Nurses Week In honor of National Nurses Week, C-Path sat down with its own Gina Smith, MPH, RN, and Smith Heavner, Ph.D., RN...
May 1, 2024 Critical Path for Parkinson’s Celebrates Foundational 10-year Milestone Critical Path Institute’s Critical Path for Parkinson’s consortium is celebrating a significant 10-year milestone today. The g
April 24, 2024 COA Program Concludes Successful Annual Meeting On April 17 and 18, Critical Path Institute’s Clinical Outcome Assessment (COA) Program hosted its Annual Meeting in Rockville,
April 23, 2024 Clinical Outcome Assessment — Initial Public Discussion In this presentation from C-Path's rare and orphan disease program, you will see...
April 10, 2024 Critical Path Institute Announces New Board Members Bonnie A. Allin and Louis Breton Critical Path Institute (C-Path) today announced the appointments of Bonnie A. Allin and Louis Breton to its Board of Directors.
March 28, 2024 C-Path Launches Clinical Trial Simulator for Duchenne Muscular Dystrophy Research Critical Path Institute’s (C-Path) Duchenne Regulatory Science Consortium (D-RSC) is excited to announce the launch of...
March 26, 2024 C-Path Launches Consortium for Alpha-1 Antitrypsin Deficiency Critical Path Institute (C-Path) is excited to announce the launch of the Critical Path for Alpha-1 Antitrypsin Deficiency...
March 25, 2024 C-Path to Spearhead New Task Force Dedicated to Accelerating Drug Development for Progressive Supranuclear Palsy Critical Path Institute (C-Path) today announced the formation of a new task force...
March 15, 2024 C-Path’s CURE Drug Repurposing Collaboratory Aims to Document 1,000 Cases on the CURE ID App for Long COVID Awareness Day TUCSON, Ariz., March 15, 2024 — Critical Path Institute’s (C-Path) CURE Drug Repurposing Collaboratory (CDRC), a leading advoc
